- Home
- Publications
- Publication Search
- Publication Details
Title
The diverse roles of SPOP in prostate cancer and kidney cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-01
DOI
10.1038/s41585-020-0314-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53
- (2020) Stewart N. Loh Biomolecules
- Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study
- (2019) E. M. Presotto et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Functional analysis of Cullin 3 E3 ligases in tumorigenesis
- (2018) Ji Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
- (2018) Remi Adelaiye-Ogala et al. CANCER RESEARCH
- The Complexity of DEK Signaling in Cancer Progression
- (2018) Yong Teng et al. CURRENT CANCER DRUG TARGETS
- Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway
- (2018) Wei Xiong et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma
- (2018) ShrawanK Singh et al. Journal of Cancer Research and Therapeutics
- SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
- (2018) Jian Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Genomics of Prostate Cancer: emerging understanding with technologic advances
- (2018) Mark A Rubin et al. MODERN PATHOLOGY
- BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
- (2018) Xiangyi Li et al. Cell Reports
- SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability
- (2018) Lin-Gao Ju et al. CELL DEATH AND DIFFERENTIATION
- Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments
- (2018) Jill J. Bouchard et al. MOLECULAR CELL
- DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4
- (2018) Xin Jin et al. MOLECULAR CELL
- SPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability
- (2018) Kim Hjorth-Jensen et al. NUCLEIC ACIDS RESEARCH
- miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer
- (2018) Junfei Xu et al. OncoTargets and Therapy
- Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability
- (2018) Xi Wei et al. Journal of Cancer
- The E2F1–miR-520/372/373–SPOP Axis Modulates Progression of Renal Carcinoma
- (2018) Meng Ding et al. CANCER RESEARCH
- PD-L1 in immune-escape of breast and prostate cancers: from biology to therapy
- (2017) Rita Bonfiglio et al. Future Oncology
- Regulation of various DNA repair pathways by E3 ubiquitin ligases
- (2017) Chandramouli Natarajan et al. Journal of Cancer Research and Therapeutics
- SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG
- (2017) Jonathan Shoag et al. JOURNAL OF CLINICAL INVESTIGATION
- Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
- (2017) Hui Wang et al. Journal of Translational Medicine
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
- (2017) Xiangpeng Dai et al. NATURE MEDICINE
- Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation
- (2017) Pingzhao Zhang et al. NATURE MEDICINE
- Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
- (2017) Hana Janouskova et al. NATURE MEDICINE
- SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein
- (2017) C Geng et al. ONCOGENE
- Ductal adenocarcinoma of the prostate: Clinical and biological profiles
- (2017) Armelle Vinceneux et al. PROSTATE
- LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
- (2017) Holly M. Nguyen et al. PROSTATE
- Molecular alterations in prostate cancer and association with MRI features
- (2017) D Lee et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable
- (2017) Vinay Prasad et al. SEMINARS IN ONCOLOGY
- Inherited determinants of early recurrent somatic mutations in prostate cancer
- (2017) Alessandro Romanel et al. Nature Communications
- Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
- (2017) Christian D. Fankhauser et al. Oncotarget
- Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy
- (2016) Yunhua Mao et al. Cancer Biomarkers
- TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
- (2016) Anna C. Groner et al. CANCER CELL
- Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
- (2016) Zhong-Qiang Guo et al. CANCER CELL
- Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
- (2016) Kimberly J. Briggs et al. CELL
- The Evolving Role of Nivolumab in Non–Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology
- (2016) Cesare Gridelli et al. Clinical Lung Cancer
- Liquid–liquid phase separation in cellular signaling systems
- (2016) P Andrew Chong et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer
- (2016) Seung-Hyun Jung et al. EUROPEAN UROLOGY
- Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel
- (2016) Ke Li et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma
- (2016) Wencai Zhao et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The ever-expanding role of HIF in tumour and stromal biology
- (2016) Edward L. LaGory et al. NATURE CELL BIOLOGY
- Structural insights into the catalysis and regulation of E3 ubiquitin ligases
- (2016) Lori Buetow et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing
- (2016) Kun Zhu et al. NUCLEIC ACIDS RESEARCH
- Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
- (2016) Lien Spans et al. Oncotarget
- c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4
- (2015) Román González-Prieto et al. CELL CYCLE
- PD-1/PD-L1 inhibitors
- (2015) Joel Sunshine et al. CURRENT OPINION IN PHARMACOLOGY
- PHD1 regulates p53-mediated colorectal cancer chemoresistance
- (2015) S. Deschoemaeker et al. EMBO Molecular Medicine
- Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing
- (2015) David Manson-Bahr et al. JOURNAL OF CLINICAL PATHOLOGY
- The DEK oncoprotein and its emerging roles in gene regulation
- (2015) C Sandén et al. LEUKEMIA
- SPOP Mutations or ERG Rearrangements Result in Enhanced Levels of ERG to Promote Cell Invasion in Prostate Cancer
- (2015) Shanshan Duan et al. MOLECULAR CELL
- Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation
- (2015) Jian An et al. MOLECULAR CELL
- SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression
- (2015) Wenjian Gan et al. MOLECULAR CELL
- miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation
- (2015) Vijay Kumar Eedunuri et al. MOLECULAR ENDOCRINOLOGY
- The unravelling of the ubiquitin system
- (2015) Aaron Ciechanover NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeting Cdc20 as a novel cancer therapeutic strategy
- (2015) Lixia Wang et al. PHARMACOLOGY & THERAPEUTICS
- A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage
- (2015) Mariana F. Gayyed et al. TUMOR BIOLOGY
- SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase
- (2015) Hengrui Zhu et al. Cell Reports
- SPOP mutation leads to genomic instability in prostate cancer
- (2015) Gunther Boysen et al. eLife
- SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
- (2015) Mirjam Blattner et al. NEOPLASIA
- Identification of speckle-type POZ protein somatic mutations in African American prostate cancer
- (2014) Wanguo Liu et al. ASIAN JOURNAL OF ANDROLOGY
- Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
- (2014) Jyotsna Batra et al. ASIAN JOURNAL OF ANDROLOGY
- Cdc20 and securin overexpression predict short-term breast cancer survival
- (2014) H Karra et al. BRITISH JOURNAL OF CANCER
- SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer
- (2014) Guoqiang Li et al. CANCER CELL
- Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
- (2014) Jian Shi et al. CANCER CELL
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor-Dependent HIF2 /VEGF Signaling Pathway
- (2014) D. He et al. CANCER RESEARCH
- Speckle-type POZ protein, SPOP, is involved in the DNA damage response
- (2014) D. Zhang et al. CARCINOGENESIS
- Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
- (2014) F. Khani et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer
- (2014) María García-Flores et al. EUROPEAN JOURNAL OF CANCER
- Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
- (2014) X. Zheng et al. GENES & DEVELOPMENT
- Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
- (2014) Donald J. Vander Griend et al. International Journal of Biological Sciences
- Differential expression of speckled POZ protein, SPOP: Putative regulation by miR-145
- (2014) Chiu-Jung Huang et al. JOURNAL OF BIOSCIENCES
- Hyperkalemic hypertension–associated cullin 3 promotes WNK signaling by degrading KLHL3
- (2014) James A. McCormick et al. JOURNAL OF CLINICAL INVESTIGATION
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks
- (2014) François Aymard et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Identification of a novel germlineSPOPmutation in a family with hereditary prostate cancer
- (2014) Kimberly A. Zuhlke et al. PROSTATE
- Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition ofc-MYCtranscription
- (2014) Lizamma Antony et al. PROSTATE
- Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
- (2014) J.-P. P. Theurillat et al. SCIENCE
- SETD2-Dependent Histone H3K36 Trimethylation Is Required for Homologous Recombination Repair and Genome Stability
- (2014) Sophia X. Pfister et al. Cell Reports
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
- (2014) Jian An et al. Cell Reports
- SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
- (2014) Sílvia Carvalho et al. eLife
- The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
- (2013) Feng Li et al. CELL
- The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications
- (2013) Pascal Genschik et al. EMBO JOURNAL
- Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium
- (2013) Dietmar Pils et al. EUROPEAN JOURNAL OF CANCER
- Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
- (2013) J. M. Simon et al. GENOME RESEARCH
- The epigenetics of epithelial-mesenchymal plasticity in cancer
- (2013) Wai Leong Tam et al. NATURE MEDICINE
- Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
- (2013) C. Geng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational and expressional analyses ofSPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers
- (2012) Min S. Kim et al. APMIS
- Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
- (2012) Gaetano Zafarana et al. CANCER
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
- (2012) Emmanuel S. Antonarakis et al. CANCER
- An integrated view of cyclin E function and regulation
- (2012) Ka Tat Siu et al. CELL CYCLE
- BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs
- (2012) Rebecca Mathew et al. NATURE
- Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes
- (2012) Swaminathan Venkatesh et al. NATURE
- Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
- (2012) Matthieu Le Gallo et al. NATURE GENETICS
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Understanding the language of Lys36 methylation at histone H3
- (2012) Eric J. Wagner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epigenetic regulation in RCC: opportunities for therapeutic intervention?
- (2012) James Larkin et al. Nature Reviews Urology
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition
- (2012) T. Bawa-Khalfe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptor Protein Self-Assembly Drives the Control of a Cullin-RING Ubiquitin Ligase
- (2012) Wesley J. Errington et al. STRUCTURE
- Disruptive Events in the Life of Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1
- (2011) C Li et al. ONCOGENE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase
- (2010) Eusebio Manchado et al. CANCER CELL
- Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor
- (2010) X. Edward Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pcif1 modulates Pdx1 protein stability and pancreatic β cell function and survival in mice
- (2010) Kathryn C. Claiborn et al. JOURNAL OF CLINICAL INVESTIGATION
- The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells
- (2010) Uta Kossatz et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
- (2010) D Hawksworth et al. PROSTATE CANCER AND PROSTATIC DISEASES
- TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells
- (2009) Misato Kikuchi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
- (2009) Qing Zhang et al. CANCER CELL
- Evidence that Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle Assembly
- (2009) Hsiao-Chun Huang et al. CANCER CELL
- Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
- (2009) A.-T. Henze et al. CANCER RESEARCH
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
- (2009) Min Zhuang et al. MOLECULAR CELL
- Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
- (2009) Brenda A. Schulman et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer
- (2009) J. Liu et al. SCIENCE
- Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts
- (2008) Kristin E. Yates et al. AGING CELL
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family
- (2008) Marcin Drag et al. BIOCHEMICAL JOURNAL
- The role of ATF-2 in oncogenesis
- (2008) Spiros A. Vlahopoulos et al. BIOESSAYS
- The Fbxw7/hCdc4 tumor suppressor in human cancer
- (2008) YingMeei Tan et al. CANCER LETTERS
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
- (2008) Bora Gurel et al. MODERN PATHOLOGY
- Bromodomain 4 activation predicts breast cancer survival
- (2008) N. P. S. Crawford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started